SFG
GBIO

SVB Financial Group’s Generation Bio GBIO Stock Holding History

SVB Financial Group’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,503
Closed -$94.9K – 17
2023
Q3 		$94.9K Sell
2,503
-285
-10% -$13.5K 0.18% 14
2023
Q2 		$153K Sell
2,788
-1,252
-31% -$57.5K 0.29% 13
2023
Q1 		$174K Sell
4,040
-1,252
-24% -$60.6K 0.33% 15
2022
Q4 		$208K Buy
+5,292
New +$278K 0.57% 16

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SVB Financial Group's GBIO Position: Q4 2023 in Review

SVB Financial Group sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 2,503 shares — an estimated $94.9K sold.

SVB Financial Group first reported a position in GBIO in Q4 2022 and held it in 4 quarters. The position peaked at $208K in Q4 2022. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • SVB Financial Group reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • SVB Financial Group sold 2,503 Generation Bio shares in Q4 2023, an estimated $94.9K.
  • SVB Financial Group first reported a position in Generation Bio in Q4 2022 and held it in 4 quarters.
  • SVB Financial Group's Generation Bio position peaked at $208K in Q4 2022.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on SVB Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.